Spark Capital

Spark Capital is a top-tier multi-stage venture firm with offices in San Francisco, New York, and Boston, investing across consumer, enterprise, fintech, and frontier technology including increasingly AI-native businesses. The firm has historically been generalist with a strong consumer and software bias, and healthcare appears in the portfolio selectively rather than as a defined vertical. Check sizes scale with stage and span from low single-digit millions at seed to twenty to fifty million dollars or more as the lead in growth rounds, with reserves attached. The natural fit for Spark is a category-defining company with strong founder pedigree, an ambitious market, and the kind of breakout trajectory that justifies a brand-name lead. Healthcare AI founders should approach if their company is fundamentally a software business with breakout consumer or enterprise dynamics, and a clinical or healthcare angle layered on top, rather than a regulated therapeutic or device. Companies whose primary economics depend on reimbursement, FDA clearance, or hospital enterprise sales will fit less naturally given the firm’s broader generalist orientation. Founders should not approach Spark unless the round is competitive and the metrics warrant a top-tier lead conversation. The best entry path is a warm introduction from a Spark portfolio founder, a respected angel, or a banker for growth rounds. Cold outreach without strong signal is unlikely to advance. Expect partner-driven engagement, fast decisive process when there is conviction, and a brand that materially helps subsequent fundraising.